Aims Drug-coated balloon catheters (DCB) are a new clinical treatment modality for
coronary and peripheral artery disease. The goal of the consensus group is to develop …

Background—Peripheral percutaneous transluminal angioplasty is fraught with a substantial
risk of restenosis and reintervention. A drug-eluting balloon (DEB) based on a novel coating …

As a common etiology for ischemic stroke, atherosclerotic carotid stenosis has been targeted
by vascular surgery since 1950s. Compared with carotid endarterectomy, carotid …

Background Intracranial atherosclerotic disease is a well-known cause of ischemic stroke.
Following the SAMMPRIS trial, medical treatment is favored over stenting. Drug-eluting …

Background The optimal treatment for patients with symptomatic severe intracranial
atherosclerotic disease is not well established. Angioplasty and stenting have been …

Background Although percutaneous transluminal angioplasty and stenting (PTAS) was an
effective and safe alternative treatment for severe intracranial atherosclerosis disease …

Purpose Endovascular therapy (EVT) represents an alternative treatment modality for
symptomatic intracranial high-grade atherosclerotic stenosis (sICAS); however …

Purpose Intracranial atherosclerosis disease (ICAD) is an essential cause of stroke. The
characteristics of effective treatment include low periprocedural risk and a sustained …

BACKGROUND: Intracranial atherosclerotic stenosis (ICAS) is responsible for 9% to 37% of
ischemic strokes. OBJECTIVE: To evaluate the clinical outcome and risk factors for in-stent …

Objectives Intracranial arteriosclerotic disease is a relevant cause of ischemic stroke
worldwide with a high recurrence rate despite best medical treatment. Following the …